Perceptions of prescription opioids among marginalized patients with hematologic malignancies in the context of the opioid epidemic: a qualitative study.

IF 3.1 2区 医学 Q2 ONCOLOGY
Journal of Cancer Survivorship Pub Date : 2024-08-01 Epub Date: 2023-04-06 DOI:10.1007/s11764-023-01370-9
Nadia A Nabulsi, Jonathan L Nazari, Todd A Lee, Pritesh R Patel, Karen I Sweiss, Thy Le, Lisa K Sharp
{"title":"Perceptions of prescription opioids among marginalized patients with hematologic malignancies in the context of the opioid epidemic: a qualitative study.","authors":"Nadia A Nabulsi, Jonathan L Nazari, Todd A Lee, Pritesh R Patel, Karen I Sweiss, Thy Le, Lisa K Sharp","doi":"10.1007/s11764-023-01370-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Opioids are essential for treating pain in hematologic malignancies (HM), yet are heavily stigmatized in the era of the opioid epidemic. Stigma and negative attitudes towards opioids may contribute to poorly managed cancer pain. We aimed to understand patient attitudes towards opioids for HM pain management, particularly among historically marginalized populations.</p><p><strong>Methods: </strong>We interviewed a convenience sample of 20 adult patients with HM during outpatient visits at an urban academic medical center. Semi-structured interviews were audio-recorded, transcribed, and qualitatively analyzed using the framework method.</p><p><strong>Results: </strong>Among 20 participants, 12 were female and half were Black. Median age was 62 (interquartile range = 54-68). HM diagnoses included multiple myeloma (n = 10), leukemia (n = 5), lymphoma (n = 4), and myelofibrosis (n = 1). Eight themes emerged from interviews that seemed to influence HM-related pain self-management, including (1) fear of opioid-related harms, (2) opioid side effects and harms to health, (3) fatalism and stoicism, (4) perceived value of opioids for HM-related pain, (5) low perceived susceptibility to opioid-related harms and externalizing blame, (6) preferences for non-opioid pain management approaches, (7) trust in providers and opioid accessibility, and (8) external sources of pain management support and information.</p><p><strong>Conclusions: </strong>This qualitative study demonstrates that fears and stigmatized views of opioids can conflict with marginalized patients' needs to manage debilitating HM-related pain. Negative attitudes towards opioids were shaped by the opioid epidemic and reduced willingness to seek out or use analgesics.</p><p><strong>Implications for cancer survivors: </strong>These findings help expose patient-level barriers to optimal HM pain management, revealing attitudes, and knowledge to be targeted by future pain management interventions in HM.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Survivorship","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11764-023-01370-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/4/6 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Opioids are essential for treating pain in hematologic malignancies (HM), yet are heavily stigmatized in the era of the opioid epidemic. Stigma and negative attitudes towards opioids may contribute to poorly managed cancer pain. We aimed to understand patient attitudes towards opioids for HM pain management, particularly among historically marginalized populations.

Methods: We interviewed a convenience sample of 20 adult patients with HM during outpatient visits at an urban academic medical center. Semi-structured interviews were audio-recorded, transcribed, and qualitatively analyzed using the framework method.

Results: Among 20 participants, 12 were female and half were Black. Median age was 62 (interquartile range = 54-68). HM diagnoses included multiple myeloma (n = 10), leukemia (n = 5), lymphoma (n = 4), and myelofibrosis (n = 1). Eight themes emerged from interviews that seemed to influence HM-related pain self-management, including (1) fear of opioid-related harms, (2) opioid side effects and harms to health, (3) fatalism and stoicism, (4) perceived value of opioids for HM-related pain, (5) low perceived susceptibility to opioid-related harms and externalizing blame, (6) preferences for non-opioid pain management approaches, (7) trust in providers and opioid accessibility, and (8) external sources of pain management support and information.

Conclusions: This qualitative study demonstrates that fears and stigmatized views of opioids can conflict with marginalized patients' needs to manage debilitating HM-related pain. Negative attitudes towards opioids were shaped by the opioid epidemic and reduced willingness to seek out or use analgesics.

Implications for cancer survivors: These findings help expose patient-level barriers to optimal HM pain management, revealing attitudes, and knowledge to be targeted by future pain management interventions in HM.

在阿片类药物流行的背景下,血液系统恶性肿瘤边缘化患者对处方阿片类药物的看法:一项定性研究。
目的:阿片类药物是治疗血液系统恶性肿瘤(HM)疼痛的基本药物,但在阿片类药物流行的时代,阿片类药物却被严重污名化。对阿片类药物的污名化和负面态度可能会导致癌症疼痛管理不善。我们旨在了解患者对阿片类药物治疗 HM 疼痛的态度,尤其是在历史上被边缘化的人群中:方法:我们在一家城市学术医疗中心对门诊就诊的 20 名成年 HM 患者进行了方便抽样调查。我们对半结构化访谈进行了录音、转录,并采用框架法进行了定性分析:在 20 名参与者中,12 人为女性,半数为黑人。中位年龄为 62 岁(四分位数间距 = 54-68)。HM 诊断包括多发性骨髓瘤(10 例)、白血病(5 例)、淋巴瘤(4 例)和骨髓纤维化(1 例)。访谈中出现了八个似乎影响 HM 相关疼痛自我管理的主题,包括:(1)对阿片类药物相关危害的恐惧;(2)阿片类药物的副作用和对健康的危害;(3)宿命论和委曲求全;(4)阿片类药物对 HM 相关疼痛的感知价值、(5) 对阿片类药物相关伤害和外部责任的低感知易感性,(6) 对非阿片类药物疼痛管理方法的偏好,(7) 对提供者和阿片类药物可及性的信任,以及 (8) 疼痛管理支持和信息的外部来源。结论:这项定性研究表明,对阿片类药物的恐惧和污名化观点可能会与边缘化患者控制令人衰弱的 HM 相关疼痛的需求相冲突。对阿片类药物的负面态度是由阿片类药物的流行以及寻求或使用镇痛剂的意愿降低所形成的:这些研究结果有助于揭示患者在最佳 HM 疼痛管理方面所面临的障碍,揭示未来 HM 疼痛管理干预措施应针对的态度和知识。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.00
自引率
10.80%
发文量
149
审稿时长
>12 weeks
期刊介绍: Cancer survivorship is a worldwide concern. The aim of this multidisciplinary journal is to provide a global forum for new knowledge related to cancer survivorship. The journal publishes peer-reviewed papers relevant to improving the understanding, prevention, and management of the multiple areas related to cancer survivorship that can affect quality of care, access to care, longevity, and quality of life. It is a forum for research on humans (both laboratory and clinical), clinical studies, systematic and meta-analytic literature reviews, policy studies, and in rare situations case studies as long as they provide a new observation that should be followed up on to improve outcomes related to cancer survivors. Published articles represent a broad range of fields including oncology, primary care, physical medicine and rehabilitation, many other medical and nursing specialties, nursing, health services research, physical and occupational therapy, public health, behavioral medicine, psychology, social work, evidence-based policy, health economics, biobehavioral mechanisms, and qualitative analyses. The journal focuses exclusively on adult cancer survivors, young adult cancer survivors, and childhood cancer survivors who are young adults. Submissions must target those diagnosed with and treated for cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信